The stock currently offers a 4% dividend yield ... We can see from my table above that Sanofi is undervalued by 55% to peers ...

Further boosting the pipeline, mid-stage drugs like Sanofi/Regeneron’s itepekimab ... 23 abstracts at the American Society of ...

Shares of NASDAQ SNY opened at $50.14 on Wednesday. The stock has a market cap of $127.25 billion, a PE ratio of 25.83, a ...

Shares of Sanofi (NASDAQ:SNY – Get Free Report) have received a consensus rating of “Moderate Buy” from the four brokerages that are currently covering the stock, Marketbeat reports. Two analysts have ...

Sanofi’s stock dropped 3.4% to $47.82, continuing a weeks-long drop in share price triggered after its latest earnings report ...

VIR's HDV and HBV treatments remain Vir's primary value drivers, with upcoming catalysts in Q4 2024 and 2025. Find out why ...

On Tuesday, Novavax Inc (NASDAQ:NVAX) reported third-quarter 2024 sales of $84.5 million, compared to $186.99 million a year, ...

Systematix upgraded the stock rating to 'hold' and hiked target price to Rs 1,414 apiece, while Dolat Capital upgraded rating ...

In a report released today, Peter Welford from Jefferies downgraded GlaxoSmithKline (GSK – Research Report) to a Hold, with a price ...